Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
Aims. To conduct an analysis of modern antihyperglycemic prescription patterns in type 2 diabetes mellitus (T2DM). Materials and methods. Russian DM State registry was studied. Results. We obtained absolute and comparative data on use of insulin analogues, dipeptidyl peptidase-4 (DPP-4) inhibitor...
Saved in:
| Main Author: | Yury Ivanovich Suntsov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2012-03-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/5971 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Incretin-Based Therapies and Cancer: What’s New?
by: Sanja Medenica, et al.
Published: (2025-04-01) -
Heart failure outcomes in patients with type 2 diabetes mellitus: findings from the cardiovascular outcome trials of antidiabetes agents
by: Stefan D. Anker
Published: (2019-12-01) -
Perioperative Considerations of Novel Antidiabetic Agents in Heart Failure Patients Undergoing Cardiac Surgery
by: Ashley Wang, et al.
Published: (2025-03-01) -
Bidirectional Interactions Between the Gut Microbiota and Incretin-Based Therapies
by: Vincenzo Trapanese, et al.
Published: (2025-05-01) -
Role of incretin based therapies in the treatment of diabetic kidney disease
by: Paola Fioretto, et al.
Published: (2018-11-01)